DB
JAZZ icon

Dmitry Balyasny’s Jazz Pharmaceuticals JAZZ Stock Holding History

Dmitry Balyasny’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,000
Closed -$4.93M – 2150
2021
Q1 		$4.93M Buy
+30,000
New +$4.94M 0.02% 704

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dmitry Balyasny's JAZZ Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 2,023 shares worth $487K. The stake represents ﹤0.01% of the portfolio and ranks #2523 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in JAZZ as recently as Q4 2025.

Dmitry Balyasny first reported a position in JAZZ in Q2 2013 and has held it in 34 quarters since. The position peaked at $57.1M in Q3 2025. 640 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Dmitry Balyasny held 2,023 shares of Jazz Pharmaceuticals worth $487K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Dmitry Balyasny position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2523 holding.
  • Dmitry Balyasny first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 34 quarters since.
  • Dmitry Balyasny's Jazz Pharmaceuticals position peaked at $57.1M in Q3 2025.
  • 640 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.